This compound is primarily used in the synthesis of pharmaceutical intermediates, particularly in the development of protease inhibitors. Its structure, featuring a difluorophenyl group, makes it valuable in creating molecules that target specific enzymes involved in disease pathways. It is often employed in medicinal chemistry research to explore potential treatments for conditions like viral infections or cancer. The benzyloxycarbonyl (Cbz) protecting group allows for controlled reactions during peptide synthesis, ensuring precise modifications. Additionally, its chiral nature is critical for producing enantiomerically pure compounds, which are essential for drug efficacy and safety.